Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome

Exclusion Criteria

• •Prior administration of therapeutic or investigational radiopharmaceuticals within 5 physical half-lives before study imaging.
• •Pregnancy or breastfeeding.
• •History of allergic reaction to gallium-based tracers or related compounds.
• •Clinically unstable condition or severe organ dysfunction that, in the investigator's opinion, would interfere with PET/CT imaging or study participation.
• •Inability to complete both 68Ga-Pentixafor and, when applicable, 68Ga-DOTATATE PET/CT imaging due to clinical or logistical reasons.